General Information of DIG (ID: E0D2FK)
DIG Name
Dextran
Synonyms    Click to Show/Hide the Synonyms of This DIG
DEXTRAN; 9004-54-0; Dextran 40; 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal; Macrodex; 13382-86-0; Dextran, for biochemistry, low fraction; Dextran, for biochemistry, high fraction; (2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal; SCHEMBL12557981; BCP13568; AKOS015915689; AK547237; D1448; D1449; DEX 500; Detrax 40; Dextranen; Dextraven; FT-0624533; FT-0624535; FT-0776551; 2,3,4,5-tetrahydroxy-6-((3,4,5-trihydroxy-6-(((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal
DIG Function
Lyophilization aid
PubChem CID
4125253
Formula
C18H32O16
Canonical SMILES
C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O
InChI
1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h1,5-18,20-30H,2-4H2
InChIKey
FZWBNHMXJMCXLU-UHFFFAOYSA-N
   Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=4125253"></iframe>
3D MOL is not available 2D MOL
Physicochemical Properties Molecular Weight 504.4 Topological Polar Surface Area 277
XlogP -7.2 Complexity 625
Heavy Atom Count 34 Rotatable Bond Count 11
Hydrogen Bond Donor Count 11 Hydrogen Bond Acceptor Count 16
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
       ICD Disease Classification 02 Benign/in-situ/malignant neoplasm Click to Show/Hide
Etoposide
API Info
Testicular carcinoma [ICD-11: 2C80]
[1]
References
1 FDA label for approved etoposide from the official website of the U.S. Food and Drug Administration.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.